Stocks Health care INSP
NYSE · Health careInspire Medical Systems, Inc. (INSP)
Inspire Medical Systems, Inc. brought in $880.9M of revenue over the twelve months to September 30, 2026, down 0.2% from a year earlier. Net income was $100.7M, a net margin of 11.4%. Operating cash flow minus capital spending left $78.5M of free cash flow in fiscal 2025. At September 30, 2026 it held $190.8M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 2, 2026.
Key facts about Inspire Medical Systems, Inc.
- Net worth
- Inspire Medical Systems, Inc. has a market value (market cap) of $1.8B at the latest share price, and shareholders' equity of $826.9M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $912M (+13.6% year on year), with net income of $145.4M. Over the 12 months to September 30, 2026: revenue $880.9M, net income $100.7M.
- Cash flow
- In fiscal 2025 operations brought in $117M of cash; after $38.5M of capital spending, free cash flow was $78.5M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 2, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Inspire Medical Systems, Inc.'s next report is expected around January 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Inspire Medical Systems, Inc. does
Inspire Medical Systems, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NYSE under the ticker INSP.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $912M | $145.4M | $4.89 | $78.5M |
| 2024 | $802.8M | $53.5M | $1.75 | $91.1M |
| 2023 | $624.8M | -$21.2M | -$0.72 | $1M |
| 2022 | $407.9M | -$44.9M | -$1.60 | $2.5M |
| 2021 | $233.4M | -$42M | -$1.54 | -$24.8M |
| 2020 | $115.4M | -$57.2M | -$2.19 | -$55.5M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where INSP ranks in Health care
Latest SEC filings
What Inspire Medical Systems, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 9, 2026Passive stake changed SCHEDULE 13G/A
- November 2, 2026Quarterly report 10-Q · period to September 30, 2026Revenue fell 7.9% to $206.7M versus the same quarter last year; diluted EPS -$0.84 versus $0.34.
- November 2, 2026
- October 30, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- August 12, 2026Passive stake (5% or more) SCHEDULE 13G
- August 3, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 7.6% to $200.6M versus the same quarter last year; diluted EPS $0.01 versus -$0.12.
- August 3, 2026
- July 31, 2026Passive stake changed SCHEDULE 13G/A
- July 28, 2026Passive stake changed SCHEDULE 13G/A
What is INSP worth? A DCF from its reported cash flow
Insider trades
What the people running Inspire Medical Systems, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 5 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 14, 2026 | Broader Shelley GDirector | Received as pay | 284 | $19.3K |
| October 14, 2026 | Carrel Michael HDirector | Received as pay | 203 | $13.8K |
| October 14, 2026 | Melenikiotou GeorgiaDirector | Received as pay | 255 | $17.4K |
| October 14, 2026 | Ellis Gary LeeDirector | Received as pay | 431 | $29.3K |
| August 31, 2026 | Kelly Jason PSee Remarks | Received as pay | 6,350 | - |
| August 7, 2026 | Kelly Jason PSee Remarks | Sold | 963 | $57.3K |
| July 31, 2026 | Mann MelissaChief People Officer | Shares withheld for tax | 326 | $16.4K |
| July 20, 2026 | Carrel Michael HDirector | Received as pay | 5,631 | - |
Who owns INSP
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Wellington Management Group LLP13G, passive with 3 related filers | 8.8% | May 15, 2026 |
| Vanguard Portfolio Management13G, passive | 7.37% | July 31, 2026 |
| AQR Capital Management, LLC13G, passive with 1 related filers | 6.44% | August 12, 2026 |
| D. E. Shaw & Co., L.P.13G, passive with 1 related filers | 5.1% | July 2, 2026 |
| Vanguard Capital Management13G, passive | 5.1% | April 30, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 275 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 4,737,519 | +1,187,965 |
| Wellington Management Group Llp | 2,382,660 | -153,294 |
| Vanguard Portfolio Management LLC | 2,088,961 | +451,788 |
| Soleus Capital Management, L.P. | 1,931,436 | +1,355,137 |
| Aqr Capital Management LLC | 1,856,800 | +1,548,138 |
| Assenagon Asset Management S.A. | 1,728,790 | +1,208,616 |
| UBS Group AG | 1,645,511 | +1,006,583 |
| D. E. Shaw & Co., Inc. | 1,470,462 | +281,925 |
| Nomura Holdings Inc | 1,369,410 | new |
| Deerfield Management Company, L.P. | 1,296,862 | -1,406,376 |
| Vanguard Capital Management LLC | 1,270,928 | +4,190 |
| State Street Corp | 1,206,494 | +250,483 |
| Morgan Stanley | 791,222 | -659,412 |
| Artisan Partners Limited Partnership | 732,323 | -48,252 |
| Geode Capital Management, LLC | 700,836 | +190,602 |
| Braidwell LP | 677,570 | 0 |
| Goldman Sachs Group Inc | 645,858 | -18,145 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 546,020 | +97,233 |
| Nantahala Capital Management, LLC | 538,948 | new |
| Citadel Advisors LLC | 506,334 | +112,258 |
Insiders
16 insiders reported holding 428,574 shares in total, about $26.8M at the last price.
| Holder | Shares |
|---|---|
| Herbert Timothy P.CEO and President, Director | 99,834 |
| Buchholz RichardInterim CFO | 43,988 |
| Weatherby CarltonSee Remarks | 41,679 |
| Phillips Bryan KSee Remarks | 38,513 |
| mcCormick ShawnDirector | 27,712 |
| Rondoni JohnSee Remarks | 27,165 |
| Tansey Casey MDirector | 26,632 |
| Mead Dana G Jr.Director | 26,213 |
| Kelly Jason PSee Remarks | 25,335 |
| Mann MelissaChief People Officer | 22,957 |
Questions about INSP
What does Inspire Medical Systems, Inc. do?
Inspire Medical Systems, Inc. is a company in the Health care sector, listed on NYSE as INSP. Its shares trade on NYSE under the ticker INSP.
What is Inspire Medical Systems, Inc.'s net worth?
Inspire Medical Systems, Inc. has a market value (market cap) of $1.8B at the latest share price, and shareholders' equity of $826.9M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Inspire Medical Systems, Inc. profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $100.7M on revenue of $880.9M, a net margin of 11.4%.
How much revenue does Inspire Medical Systems, Inc. make?
Over the twelve months to September 30, 2026 Inspire Medical Systems, Inc. reported revenue of $880.9M. That is 0.2% less than a year earlier.
When did Inspire Medical Systems, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 2, 2026. It covers the period to September 30, 2026. Its newest filing of any kind is the passive stake changed from November 9, 2026.
When is Inspire Medical Systems, Inc.'s next earnings report?
Inspire Medical Systems, Inc.'s next report is expected around January 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare INSP with
Follow INSP
Get an email when Inspire Medical Systems, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Inspire Medical Systems, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.